tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Novartis AG (GB:0QLR)
LSE:0QLR
US Market
0QLR
Novartis AG
RESEARCH TOOLSreports

Novartis AG (0QLR) Stock News & Sentiment

Compare
12 Followers
Novartis AG: Visible Earnings, Supportive Guidance and Attractive Risk‑Reward Underpin Buy Rating
Premium
Ratings
Novartis AG: Visible Earnings, Supportive Guidance and Attractive Risk‑Reward Underpin Buy Rating
2d ago
NVS
Looking for Exposure to Johnson & Johnson Stock (JNJ) ahead of Q4 Earnings? Here’s How to Buy Without the Risk
Premium
Market News
Looking for Exposure to Johnson & Johnson Stock (JNJ) ahead of Q4 Earnings? Here’s How to Buy Without the Risk
11d ago
BMY
IHE
Novartis: Buy Rating Backed by Strong Rx Momentum, De-Risked Late-Stage Pipeline and Attractive Valuation
Premium
Ratings
Novartis: Buy Rating Backed by Strong Rx Momentum, De-Risked Late-Stage Pipeline and Attractive Valuation
14d ago
NVS
Novartis AG: Strong Growth Potential and Strategic Innovations Justify Buy Rating
Premium
Ratings
Novartis AG: Strong Growth Potential and Strategic Innovations Justify Buy Rating
2M ago
NVS
Novartis AG: Strong Growth Potential Amid Patent Expirations with Robust Pipeline and Strategic Phase III Trials
Premium
Ratings
Novartis AG: Strong Growth Potential Amid Patent Expirations with Robust Pipeline and Strategic Phase III Trials
2M ago
NVS
Novartis AG: Hold Rating Amid Moderate Growth and Valuation Concerns
Premium
Ratings
Novartis AG: Hold Rating Amid Moderate Growth and Valuation Concerns
2M ago
NVS
Cautious Hold on Novartis AG Amid Mixed Ianalumab Data and Valuation Concerns
Premium
Ratings
Cautious Hold on Novartis AG Amid Mixed Ianalumab Data and Valuation Concerns
3M ago
NVS
More GB:0QLR News >

0QLR News on the Web

Novartis AG: Visible Earnings, Supportive Guidance and Attractive Risk‑Reward Underpin Buy Rating
TipRanks News
Bullish
Novartis initiated with a Buy at Citi
TipRanks News
Bullish
Bank of America Securities Initiates a Buy Rating on Novartis AG (NOVN)
TipRanks News
Bullish
AI Daily: Nvidia invests $2B in CoreWeave
TipRanks News
Neutral
Erste Group Sticks to Their Buy Rating for Novartis AG (NOVN)
TipRanks News
Bullish
Drugmakers use AI to help progress through trials, submissions, Reuters says
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Novartis AG (NOVN), BioVersys AG (Six Swiss: CH:BIOV) and Gilead Sciences (GILD)
TipRanks News
Neutral
Looking for Exposure to Johnson & Johnson Stock (JNJ) ahead of Q4 Earnings? Here’s How to Buy Without the Risk
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
GB:0QLR
Sector Average
Media Buzz
This Week6 articles
Weekly Average6.75 articles
News Sentiment
This Week100%
Sector Average75%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0QLR’s Media Buzz Sentiment?
6 articles about GB:0QLR were published this week. In an average week, 6.75 articles are published.
    What is GB:0QLR’s weekly average amount of articles?
    In an average week, 6.75 articles about GB:0QLR are published.
      What is GB:0QLR’s News Sentiment?
      100% of articles about GB:0QLR were positive this week, compared to its sector average of 75%.
        Healthcare Stocks that are Trending in the News
        HOCPFHOYA
        CBLControl Bionics Ltd.
        CRDFCardiff Oncology
        KRROKorro Bio
        IMAImageneBio
        Showing the stocks with the most bullish news sentiment over the past week